R&D Parkinson’s Awareness Month may end, but the research impera... As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.
Oncology The role of advanced imaging in transforming early detection... The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
